KRYS
Krystal Biotech Inc
NASDAQ: KRYS · HEALTHCARE · BIOTECHNOLOGY
$259.95
-3.46% today
Updated 2026-04-29
Market cap
$7.65B
P/E ratio
38.06
P/S ratio
19.66x
EPS (TTM)
$6.83
Dividend yield
—
52W range
$123 – $298
Volume
0.3M
Krystal Biotech Inc (KRYS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
52.60%
Operating margin
41.30%
ROE
18.90%
ROA
8.44%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-1.15M | — | — | — |
| 2017 | $0.00 | $-7.92M | — | — | — |
| 2018 | $1.03M | $-10.89M | 86.27% | -1,160.27% | -1,060.27% |
| 2019 | $0.00 | $-19.09M | — | — | — |
| 2020 | $0.00 | $-32.17M | — | — | — |
| 2021 | $0.00 | $-69.57M | — | — | — |
| 2022 | $0.00 | $-139.97M | — | — | — |
| 2023 | $50.70M | $10.93M | 93.90% | -216.43% | 21.56% |
| 2024 | $290.51M | $89.16M | 93.09% | 22.61% | 30.69% |
| 2025 | $389.13M | $204.83M | 92.61% | 41.45% | 52.64% |